This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer
Clinical trial NCT03433898 · COMPLETED
Trial details
- NCT number
- NCT03433898
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-23
- Primary completion
- 2023-07-20
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.